Page 169 - ASHG 2012 Annual Meeting Program Guide

158
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Birayavci, S. Yilmaz Susluer, Z. O. Dogan Sigva, T. Balci,
G. Saydam, C. Gunduz.
1179
W The X-linked tumor suppressor TSPX disrupts
the positive feedback loop of the viral oncoprotein HBx
in HBV-associated hepatocarcinogenesis.
T. Kido, Y.-F.
C. Lau.
1180
T Comparison of minor groove binding
ligands and known carcinogen blastomogenic,
recombinogenic and mutagenic activity revealed by
SMART in wts/
1
hetesozygous flies.
K. Kirsanov, E.
Lesovaya, G. Belitsky, M. Yakubovskaya.
1181
F GR-mediated regulation of gene expression by
standard glucocorticoids and selective glucocorticoid
receptor agonists in lymphoma cells.
E. Lesovaya, A.
Yemelyanov, K. Kirsanov, V. Gasanova, M. Yakubovskaya,
I. Budunova.
1182
W Sub-cellular localization of Y-box protein 1
regulates proliferation, migration and tumorigenicity
in astrocytomas.
X. Liu, D. Faury, C. Sollier, N. Gerges,
B. Meehan, Z. Dong, P. Siegel, A. Korshunov, S. Pfister, J.
Rak, N. Jabado.
1183
T Integrative analysis of TCGA clinical and
genomic data reveals conflicting roles of
REST
gene expression in recurrent glioblastoma.
J.
Madhusoodanan, M. Shekar, J. Su, I. Kupershmidt.
1184
F Analysis of
MRE11/RAD50/NBN
genes in
childhood acute lymphoblastic leukemia.
J. Nowak,
M. Mosor, I. Ziolkowska-Suchanek, K. Nowicka, D.
Januszkiewicz-Lewandowska.
1185
W Validation of a prostate cancer metastasis
signature in a FFPE cohort of primary tumors.
A.
Pearlman, C. Campbell, J. Loke, S. Freedland, Y. Shao,
H. Ostrer.
1186
T Molecular characterization of small cell
carcinoma of the ovary.
P. Ramos, M. L. Russell, L.
Nordstrom, S. Smith, M. T. Barrett, T. Holley, E. Lenkiewitz,
J. G. Pressey, J. Farley, S. P. Anthony, G. Hostetter, A. E.
McCullough, K. A. Furge, B. B. Haab, J. M. Trent, H. E.
Cunliffe.
1187
F Effects of
Helicobacter pylori
infection on
MGMT
and
MLH1
promoter methylation status
and microsatellite instability in pediatric and adult
patients.
M. L. Ribeiro, M. C. Alvarez, J. C. Santos,
N. M. Maniezzo, M. S. Ladeira, I. C. A. Scaletsky, J.
Pedrazzoli, Jr.
1188
W Role of novel and GWAS identified
PLCE1
genetic variants to gallbladder cancer susceptibility
in north Indian population.
K. L. Sharma, S. Misra, A.
Kumar, B. Mittal.
1189
T Serum metabolomics and prostate cancer
survival.
R. Szulkin, R. Karlsson, A. Heuberger, M. Hong,
C. Broeckling, J. Prenni, J. Prince, F. Wiklund.
T. Morad, S. Allon-Shalev, AM. Lichanska, LA. Borsuk,
C. Tibbetts.
1166
F A new approach for an anti-diabetic drug
metformin in prostate cancer.
C. Biray Avci, E. Harman,
S. Yilmaz, Y. Dodurga, C. Gunduz.
1167
W mRNA-seq of single prostate cancer circulating
tumor cells reveals recapitulation of gene expression
and pathways found in prostate cancer.
G. Cann, Z.
Gulzar, S. Cooper, M. Tat, R. Li, S. Stuart, S. Luo, M.
Ronaghi, J. Brooks, A. Talasar.
1168
T Detection of sequences of MMTV-like
retroviruses in breast cancer from Mexican women.
A. Cedro-Tanda, I. A. Cordova-Solis, D. J. Arenas-
Aranda, J. Torres-López, F. A. Salamanca-Gomez, C.
Moctezuma-Meza, G. Castelazo-Rodriguez, N. Garcia-
Hernandez.
1169
F Expression of stem cell gene,
Piwil2
and
testis specific genes
TSGA10, TEX101
and
ODF3
in breast cancer.
M. Dianatpour, P. Mehdipour, M.
Miryounesi, S. Savad, F. Yazarlou, M. Mobasheri, M. H.
Modarressi.
1170
W
PMS2
screening: Could massive parallel
sequencing facilitate gene analysis?
J. Duclos, F. Pires,
G. Legrand, C. Colas, J. Lefevre, M. Eyries, C. Wang, Y.
Parc, F. Soubrier, F. Coulet.
1171
T
FANCD2
immunohistochemical expression is
a prognostic marker in breast cancer.
R. Fagerholm,
K. M. Sprott, T. Heikkinen, J. Bartkova, P. Heikkilä, K.
Aittomäki, J. Bartek, D. T. Weaver, C. Blomqvist, H.
Nevanlinna.
1172
F Effects of cassia extracts on cytotoxicity,
apoptosis and gene expression in HL-60 cells.
C.
Gündüz, S. Yilmaz Süslüer, B. Agrap, C. Biray Avci, F.
Lermioglu.
1173
W Universal Lynch syndrome screening result
notification: Efficacy affected by method.
H. Hampel, I.
Lattimer, W. L. Frankel.
1174
T Allele-specific expression imbalances of
MCC
and reduced susceptibility to colorectal cancer in
schizophrenia.
L. He, G. He.
1175
F RAD51 polymorphisms and breast cancer risk.
M. Hosseini, M. Houshmand, A. Ebrahimi.
1176
W Design and development of a next-generation
sequencing assay for multiplex detection of somatic
mutations in FFPE tissues.
E. B. Jaeger, R. Haigis, M.
Bauer, J. Yeakley, J. Betley, N. Udar.
1177
T Genotypic distribution of MMP1 (1607, 1G/2G)
promoter in childhood malignant gliomas.
P. Kawal, R.
Kumar, A. Chandra, T. N. Dhole, B. K. Ojha.
1178
F Antileukemic effect of paclitaxel in combination
with metformin in HL-60 cell line.
C. Kayabasi, C.